- Home
- MYGN vs KIDS Comparison
MYGN vs KIDS Comparison
Compare MYGN & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- KIDS
- Stock Information
- Founded
- MYGN 1991
- KIDS 2007
- Country
- MYGN United States
- KIDS United States
- Employees
- MYGN N/A
- KIDS N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- KIDS Medical/Dental Instruments
- Sector
- MYGN Health Care
- KIDS Health Care
- Exchange
- MYGN Nasdaq
- KIDS Nasdaq
- Market Cap
- MYGN 744.7M
- KIDS 601.5M
- IPO Year
- MYGN 1995
- KIDS 2017
- Fundamental
- Price
- MYGN $4.92
- KIDS $20.29
- Analyst Decision
- MYGN Hold
- KIDS Buy
- Analyst Count
- MYGN 15
- KIDS 7
- Target Price
- MYGN $15.14
- KIDS $35.71
- AVG Volume (30 Days)
- MYGN 2.1M
- KIDS 139.2K
- Earning Date
- MYGN 08-05-2025
- KIDS 08-04-2025
- Dividend Yield
- MYGN N/A
- KIDS N/A
- EPS Growth
- MYGN N/A
- KIDS N/A
- EPS
- MYGN N/A
- KIDS N/A
- Revenue
- MYGN $831,300,000.00
- KIDS $212,453,000.00
- Revenue This Year
- MYGN N/A
- KIDS $19.23
- Revenue Next Year
- MYGN $6.68
- KIDS $17.14
- P/E Ratio
- MYGN N/A
- KIDS N/A
- Revenue Growth
- MYGN 7.38
- KIDS 31.28
- 52 Week Low
- MYGN $3.81
- KIDS $19.52
- 52 Week High
- MYGN $29.30
- KIDS $35.99
- Technical
- Relative Strength Index (RSI)
- MYGN 46.03
- KIDS 40.70
- Support Level
- MYGN $4.78
- KIDS $19.99
- Resistance Level
- MYGN $5.29
- KIDS $21.55
- Average True Range (ATR)
- MYGN 0.32
- KIDS 0.78
- MACD
- MYGN 0.11
- KIDS -0.05
- Stochastic Oscillator
- MYGN 60.98
- KIDS 27.05
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.